Spotlights on Recent JACS Publications

摘要

There is tremendous interest in "drugging" the adaptive immune system, for example to dampen auto-immune disease or to stimulate an anti-cancer response. However, current immune-targeted drugs are limited in that they cannot distinguish one immune response from another, resulting in general immunosuppression or stimulation. Ideally, researchers would like to target only the "good" or "bad" immune responses with a new generation of drugs.